InsidersTradesSigma
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Hamdy Ahmed MD, Chairman & CEO. Insider active across 1 company, notably Vincerx Pharma, Inc.. Aggregated, 7 filings have been published. Split: 7 buys · 0 sell. Total volume traded: €358k. History available since 29 June 2021. The latest transaction was disclosed on 9 August 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
7 of 7 declarations
Hamdy Ahmed MD is the Chief Executive Officer of Vincerx Pharma, Inc. In this role, he is responsible for the strategic direction and operations of the company. His experience in the pharmaceutical sector enables him to lead innovative initiatives and foster Vincerx's growth. He plays a key role in developing new therapeutic solutions.